119th Congress
H.R. 3821
ADINA Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Kelly Morrison(D-MN)
- Introduced
- Jun 6, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (21)
Original cosponsors (5)
- Ben Cline (R-VA)
- Brian K. Fitzpatrick (R-PA)
- Don Bacon (R-NE)
- Doris O. Matsui (D-CA)
- Michael Lawler (R-NY)
Added later (16)
- Angie Craig (D-MN) · Jun 23, 2025
- Sharice Davids (D-KS) · Aug 15, 2025
- Glenn Grothman (R-WI) · Nov 4, 2025
- Mike Quigley (D-IL) · Nov 4, 2025
- Chellie Pingree (D-ME) · Nov 7, 2025
- Eleanor Holmes Norton (D-DC) · Nov 7, 2025
- André Carson (D-IN) · Nov 19, 2025
- Addison P. McDowell (R-NC) · Dec 10, 2025
- Shri Thanedar (D-MI) · Jan 8, 2026
- Maxwell Frost (D-FL) · Mar 3, 2026
- Jefferson Van Drew (R-NJ) · Mar 17, 2026
- Josh Gottheimer (D-NJ) · Mar 25, 2026
- Eric Sorensen (D-IL) · Jun 2, 2026
- Stephanie I. Bice (R-OK) · Jun 2, 2026
- Josh Riley (D-NY) · Jul 9, 2026
- Sarah McBride (D-DE) · Sep 10, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug intended for human use to identify each ingredient in such drug that is, or is derived directly or indirectly from, a major food allergen or a gluten-containing grain, and for other purposes.
Latest action(Jun 6, 2025): Referred to the House Committee on Energy and Commerce.
Roll-call votes
No recorded votes on this bill.
Actions
- Jun 6, 2025 · House
Referred to the House Committee on Energy and Commerce. - Jun 6, 2025
Sponsor introductory remarks on measure. (CR H2516) - Jun 6, 2025
Introduced in House